Pzena Investment Management LLC Acquires 7,615 Shares of Cigna Group $CI

Pzena Investment Management LLC lifted its holdings in shares of Cigna Group (NYSE:CI) by 1.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 578,448 shares of the health services provider’s stock after acquiring an additional 7,615 shares during the quarter. Pzena Investment Management LLC’s holdings in Cigna Group were worth $154,301,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in CI. Banco Bilbao Vizcaya Argentaria S.A. increased its stake in shares of Cigna Group by 13.5% during the third quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after purchasing an additional 4,066 shares during the period. Distillate Capital Partners LLC boosted its stake in Cigna Group by 19.1% in the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock valued at $31,338,000 after purchasing an additional 17,442 shares during the period. Cooperman Leon G grew its holdings in Cigna Group by 53.3% in the 3rd quarter. Cooperman Leon G now owns 325,000 shares of the health services provider’s stock valued at $93,681,000 after buying an additional 113,000 shares in the last quarter. Schroder Investment Management Group grew its holdings in Cigna Group by 53.0% in the 3rd quarter. Schroder Investment Management Group now owns 190,710 shares of the health services provider’s stock valued at $54,972,000 after buying an additional 66,090 shares in the last quarter. Finally, apricus wealth LLC increased its position in Cigna Group by 715.9% during the 4th quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after buying an additional 8,340 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of NYSE CI opened at $276.67 on Thursday. The stock’s fifty day simple moving average is $284.61 and its 200 day simple moving average is $279.09. The stock has a market capitalization of $73.19 billion, a price-to-earnings ratio of 11.73, a PEG ratio of 1.06 and a beta of 0.28. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 52-week low of $239.51 and a 52-week high of $332.29.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the company posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, sell-side analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were paid a $1.56 dividend. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on CI shares. Mizuho lifted their target price on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Sanford C. Bernstein raised their price target on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 5th. Wells Fargo & Company lifted their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. Cantor Fitzgerald boosted their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday, May 1st. Finally, Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $338.30.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.